Cannell & Co. Johnson & Johnson Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Johnson & Johnson stock. As of the latest transaction made, Cannell & Co. holds 129,265 shares of JNJ stock, worth $20.1 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

129,265

Previous 128,982 0.22%

Holding current value

$20.1 Million

Previous $20.1 Million 0.86%

% of portfolio

0.67%

Previous 0.71%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$145.6 - $158.88 $41,204 - $44,963	283 Added 0.22%	129,265 $20.3 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $768,314 - $860,709	-4,933 Reduced 3.68%	128,982 $20.1 Million
Q2 2023 Aug 09, 2023	SELL	$154.35 - $166.11 $268,569 - $289,031	-1,740 Reduced 1.28%	133,915 $22.2 Million
Q1 2023 May 08, 2023	SELL	$151.05 - $180.26 $243,492 - $290,579	-1,612 Reduced 1.17%	135,655 $21 Million
Q4 2022 Feb 03, 2023	SELL	$160.2 - $179.79 $83,304 - $93,490	-520 Reduced 0.38%	137,267 $24.2 Million
Q3 2022 Nov 02, 2022	SELL	$161.33 - $179.52 $6,453 - $7,180	-40 Reduced 0.03%	137,787 $22.5 Million
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $349,498 - $386,528	-2,078 Reduced 1.49%	137,827 $24.5 Million
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $120,818 - $137,206	764 Added 0.55%	139,905 $24.8 Million
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $118,039 - $130,968	-757 Reduced 0.54%	139,141 $23.8 Million
Q3 2021 Nov 10, 2021	BUY	$161.5 - $179.47 $36,014 - $40,021	223 Added 0.16%	139,898 $22.6 Million
Q2 2021 Aug 09, 2021	SELL	$159.48 - $171.07 $6.04 Million - $6.48 Million	-37,898 Reduced 21.34%	139,675 $23 Million
Q1 2021 May 07, 2021	BUY	$153.07 - $170.48 $39,645 - $44,154	259 Added 0.15%	177,573 $29.2 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $107,357 - $123,228	-783 Reduced 0.44%	177,314 $27.9 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $9,124 - $9,998	-65 Reduced 0.04%	178,097 $26.5 Million
Q2 2020 Aug 07, 2020	SELL	$128.81 - $155.51 $80,506 - $97,193	-625 Reduced 0.35%	178,162 $25.1 Million
Q1 2020 May 05, 2020	SELL	$111.14 - $153.99 $309,524 - $428,862	-2,785 Reduced 1.53%	178,787 $23.4 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $4.28 Million - $4.91 Million	-33,550 Reduced 15.6%	181,572 $26.5 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $466,922 - $522,790	3,678 Added 1.74%	215,122 $27.8 Million
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $314,104 - $345,454	-2,395 Reduced 1.12%	211,444 $29.5 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $1.28 Million - $1.42 Million	10,163 Added 4.99%	213,839 $29.9 Million
Q4 2018 Feb 11, 2019	SELL	$122.84 - $147.84 $91,024 - $109,549	-741 Reduced 0.36%	203,676 $26.3 Million
Q3 2018 Nov 05, 2018	BUY	$121.58 - $142.88 $45,957 - $54,008	378 Added 0.19%	204,417 $28.2 Million
Q2 2018 Aug 06, 2018	BUY	$119.4 - $131.76 $295,515 - $326,106	2,475 Added 1.23%	204,039 $24.8 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $392,063 - $464,270	-3,134 Reduced 1.53%	201,564 $25.8 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $1.5 Million - $1.65 Million	-11,464 Reduced 5.3%	204,698 $28.6 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $28 Million - $29.3 Million	216,162	216,162 $28.1 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account